When BWD gets five thumbs down for blasting rummdum - you can be pretty sure that the dishonest vet picked up a few more ID's over the weekend.
Re: FaceTheFacts INSM Longs - Iplex
By biowatchdog . Nov 25, 2012 11:44 PM . Permalink Go to topic
oh, brother! Iplex is "discontinued" for neither reason you provide. You have no clue to the iPlex development program and management's strategic rationale. Such the expert! And your expertise on Premacure is dumbfounding...you probably think Premiplex is not be being produced. Oh, wait....nothing is real until the clinical trial info is updated.
I didn't see that message from bwd. He does not sound at all like the bwd of old. Just sayin'.
I will say that on the Premacure front, the vet is making more sense than he had previously with the exception that Insmed owns the ip and that premiplex is licensed...he seems to miss that point. I also contend that a 5-15% royalty is still not going to move INSM sp much. Does anyone know what the royalty is for the license?
Most importantly is the lack of communication from mgmt on anything remotely related to iplex. I do agree with many here that they should be disclosing what is going on with an asset that we the shareholders own rather than having to have it tweezed from PRs hither and 'yon.
Finally, if bwd knows what is going on in the iplex development program he needs to put up the information rather than playing a childish shell game that reminds us all of a few other posters here. His game of playing "I know something you don't know" is tiresome and he is now just another average poster that seems to be insistent that Insmed is run by the smartest buys in the room. I don't recall that bwd has uttered a discouraging word...ever.
BWD knows absolutly nothing more than anyone else here. He is no fly on the wall in the company boardroom. No one outside the inner circle of the company knows anything. If they do they then have insider information and can go to jail.